Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

NDTPNDT Pharmaceuticals Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About NDT Pharmaceuticals Inc. (NDTP)

NDT Pharmaceuticals Inc. (NDTP) is a Biotechnology company headquartered in LIVERPOOL, NY, United States whose shares trade over-the-counter on the Pink tier.

NDT Pharmaceuticals, Inc has acquired all rights under a Sponsored Research Agreement with the University of Pennsylvania, including rights to use the University's NPC technology and Intellectual Property. The Intellectual Property includes a versatile and widely applicable biotechnology asset base, including the Nanoscale Particle Complex ("NPC") technology, which represents the leading edge of phospholipid-based nano-encapsulation delivery systems that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth. Encapsulated actives are protected from destruction in the highly acidic environment of the stomach until they reach the small intestine, providing for much greater absorption of payloads. The instant delivery aspect (an Oral IV) is designed to provide the consumer with rapid effect upon consumption of the product containing the NPC technology. The NPC technology also incorporates a potent active ingredient that stimulates repair of damaged cell tissue branded by the Company as "Cell Armor." The Company is now focused on developing products utilizing this Intellectual Property.

Products and services

The Company is now focused on developing products utilizing the Intellectual Property described above.

NDTP key facts

Ticker symbol
NDTP
Market tier
Pink
Headquarters
LIVERPOOL, NY, United States
Country of incorporation
US
Year of incorporation
2007
Employees
2
Estimated market cap
$11.22M (as of Apr 15, 2025)
Shares outstanding
160,004,349
Reporting standard
Alternative Reporting Standard
Audit status
Unaudited
Fiscal year end
12/31
Latest filing
Annual Report (Dec 31, 2024)

NDT Pharmaceuticals Inc. leadership

  • Joseph C. Passalaqua — President, Treasurer, Secretary

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with N

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for NDT Pharmaceuticals Inc. (NDTP) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
7325 OSWEGO ROAD
LIVERPOOL, NY, 13090
United States

Company Leadership

Company Officers

Joseph C. Passalaqua
President, Treasurer, Secretary

Social Media

Business Details

Stock Details

Loading modules...